Sanoff HK,Sargent DJ,Campbell ME,et al.Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer N9741[J].J Clin Oncol,2008,26(35):5 721-5 727.
[2]
Lu Z,Xiao Z,Liu F,et al.Long non-coding RNAHULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1(SPHK1)[J].Oncotarget,2016,7(1):241-254.
[3]
Huang G,Wu X,Li S,et al.The long noncoding RNACASC2functions as a competing endogenous RNA by sponging miR-18ain colorectal cancer[J].Sci Rep,2016,6:26 524.
[4]
Liu YW,Sun M,Xia R,et al.LincHOTAIR epigenetically silences miR34aby binding to PRC2to promote the epithelial-to-mesenchymal transition in human gastric cancer[J].Cell Death Dis,2015,6:e1802.
[5]
Yang P,Chen T,Xu Z,et al.Long noncoding RNAGAPLINC promotes invasion in colorectal cancer by targeting SNAI2through binding with PSF and NONO[J].Oncotarget,2016,7(27):42 183-42 194.
[6]
Zhang Z,Zhou C,Chang Y,et al.Long non-coding RNA CASC11interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer[J].Cancer Lett,2016,376(1):62-73.
[7]
Li SP,Xu HX,Yu Y,et al.LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1signaling pathway[J].Oncotarget,2016,7(27):42 431-42 446.
[8]
Rerknimitr R,Angsuwatcharakon P,Ratanachu-ek T,et al.Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma[J].J Gastroenterol Hepatol,2013,28(4):593-607.
[9]
Orom UA,Derrien T,Beringer M,et al.Long noncoding RNAs with enhancer-like function in human cells[J].Cell,2010,143(1):46-58.
[10]
Ma Y,Yang Y,Wang F,et al.Long non-coding RNACCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α[J].Gut,2016,65(9):1 494-1 504.
